- Report
- February 2026
- 35 Pages
Canada
From €4522EUR$4,995USD£3,874GBP
- Report
- February 2026
- 30 Pages
Australia
From €4522EUR$4,995USD£3,874GBP
- Report
- February 2026
- 31 Pages
India
From €4522EUR$4,995USD£3,874GBP
- Report
- February 2026
- 41 Pages
India
From €4522EUR$4,995USD£3,874GBP
- Report
- February 2026
- 35 Pages
Germany
From €4522EUR$4,995USD£3,874GBP
- Report
- February 2026
- 34 Pages
Canada
From €4522EUR$4,995USD£3,874GBP
- Report
- August 2025
- 39 Pages
Africa, Middle East
From €453EUR$500USD£388GBP
- Report
- August 2025
- 43 Pages
North America
From €453EUR$500USD£388GBP
- Report
- August 2025
- 42 Pages
Europe
From €453EUR$500USD£388GBP
- Report
- August 2025
- 42 Pages
Asia Pacific
From €453EUR$500USD£388GBP
- Report
- August 2025
- 46 Pages
Global
From €453EUR$500USD£388GBP
- Clinical Trials
- June 2025
Global
From €3123EUR$3,450USD£2,675GBP
- Clinical Trials
- June 2025
Global
From €3123EUR$3,450USD£2,675GBP
- Report
- June 2025
- 33 Pages
Global
From €9048EUR$9,995USD£7,751GBP
- Report
- June 2025
- 46 Pages
Global
From €9048EUR$9,995USD£7,751GBP
- Report
- May 2025
- 134 Pages
Global
From €16289EUR$17,995USD£13,955GBP
- Report
- May 2025
- 71 Pages
Global
From €3164EUR$3,495USD£2,710GBP
- Clinical Trials
- May 2025
- 155 Pages
Global
From €3123EUR$3,450USD£2,675GBP
- Clinical Trials
- May 2025
- 252 Pages
Global
From €3123EUR$3,450USD£2,675GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €3123EUR$3,450USD£2,675GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more